Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1100 Records) |
| Query Trace: Colorectal Neoplasms and Braf[original query] |
|---|
| The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches. Oncology research 2024 9 32 (9): 1407-1422. Rossana Roncato, Jerry Polesel, Federica Tosi, Elena Peruzzi, Erika Brugugnoli, Claudia Lauria Pantano, Maria Furfaro, Filippo DI Girolamo, Alessandro Nani, Arianna Pani, Noemi Milan, Elena DE Mattia, Andrea Sartore-Bianchi, Erika Cecch |
| Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2. Oncology research 2024 9 32 (9): 1429-1438. Yuzhi Liu, Evelyne Bischof, Zhiqin Chen, Jiahuan Zhou, Bei Zhang, Ding Zhang, Yong Gao, Ming Qu |
| BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer. European journal of cancer (Oxford, England : 1990) 2024 8 210 114290. Margherita Ambrosini, David Tougeron, Dominik Modest, Rosine Guimbaud, Scott Kopetz, Marie Decraecker, Stefano Kim, Clelia Coutzac, Geraldine Perkins, Emily Alouani, Federica Marmorino, Simon Pernot, Frank A Sinicrope, Elena Elez, Pauline Parent, Chiara Cremolini, Filippo Pietrantonio, Sara Lonardi, Claire Gallois, Julien Tai |
| PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes. Cancer genomics & proteomics 2024 8 21 (5): 533-548. Ioannis A Voutsadak |
| Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient. JCO precision oncology 2024 8 8 e2400031. Florence T H Wu, James T Topham, Chris J O'Callaghan, Harriet Feilotter, Hagen F Kennecke, Leylah Drusbosky, Daniel J Renouf, Derek J Jonker, Dongsheng Tu, Eric X Chen, Jonathan M Lor |
| Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI. ESMO open 2024 8 9 (9): 103677. A H S Alig, D P Modest, S Stintzing, K Heinrich, M Geissler, L Fischer von Weikersthal, T Decker, U Vehling-Kaiser, S Held, N Moosmann, A Stahler, A Tannapfel, C Giessen-Jung, A Jung, L Weiss, V Heinema |
| Association of genetic ancestry with molecular tumor profiles in colorectal cancer. Genome medicine 2024 8 16 (1): 99. Brooke Rhead, David M Hein, Yannick Pouliot, Justin Guinney, Francisco M De La Vega, Nina N Sanfo |
| Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. Journal of translational medicine 2024 7 22 (1): 646. Christin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, Vegar J Dagenborg, Ida S Frøysnes, Mette M Larsen, Ben Davidson, Stein G Larsen, Kjersti Flatma |
| [Clinicopathological features and prognosis of sporadic mismatch repair deficient colorectal cancer]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 7 53 (7): 702-708. H Wang, R P Hong, J C Chen, J Wang, Z J Zhang, X Y Ren, H W Wu, Z Y Lia |
| Evaluation of Fluctuations of BRAF Gene Expression and its Polymorphism at rs1267623 in Colorectal Cancer. MicroRNA (Shariqah, United Arab Emirates) 2024 7 . Seyedeh Elham Norollahi, Kosar Babaei, Sogand Vahidi, Seyed Javad Hosseini Motaz, Mahmoud Kalani Tarbeghan, Mostafa Khaleghipour, Elaheh Asghari Gharakhyli, Seyed Reza Mirhafez, Ali Akbar Samada |
| Comprehensive analysis of gene mutations and mismatch repair in Chinese colorectal cancer patients. World journal of gastrointestinal oncology 2024 7 16 (6): 2673-2682. Huang Chen, Rui-Ying Jiang, Zhan Hua, Xiao-Wei Wang, Xiao-Li Shi, Ye Wang, Qian-Qian Feng, Jie Luo, Wu Ning, Yan-Fen Shi, Da-Kui Zhang, Bei Wang, Jian-Zheng Jie, Ding-Rong Zho |
| High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations. World journal of oncology 2024 7 15 (4): 612-624. Didik Setyo Heriyanto, Naomi Yoshuantari, Gilang Akbariani, Vincent Lau, Hanifa Hanini, Zulfa Hidayati, Muhammad Zulfikar Arief, Andrew Nobiantoro Gunawan, Asep Muhamad Ridwanuloh, Wien Kusharyoto, Adeodatus Yuda Handaya, Mohammad Ilyas, Johan Kurnianda, Susanna Hilda Hutajulu, Susanti Susan |
| Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2024 6 . Julien Hoba, Adrien Grancher, Vincent Hautefeuille, Anthony Turpin, Karine Bouhier-Leporrier, Marie-Pierre Galais, Anne-Laure Bignon, Aude Di Fiore, Romain Desgrippes, Laurent Miglianico, Benoit Avisse, Mathieu Baconnier, You-Heng Lam, Marie Dutherage, David Sefrioui, Karine Le Malicot, Jean-Marc Phelip, Pierre Michel, André Gillibert, Frédéric Di Fio |
| VIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort Study. Clinical colorectal cancer 2024 6 . Yijiao Chen, Dexiang Zhu, Yiyi Yu, Wenju Chang, Lechi Ye, Qingyang Feng, Pingping Xu, Miao Chen, Meiling Ji, Ye Wei, Tianshu Liu, Jianmin |
| Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants. Cancer biology & medicine 2024 6 21 (6): 473-83. Shuyi Chen, Jing Gu, Kaichun Wu, Xiaodi Zhao, Yuanyuan |
| Predictors for dMMR colorectal cancer in patients with serrated lesions and polyps - A register-based cohort study. Cancer epidemiology 2024 6 91 102601. Mille Kyhn Andrea, Rikke Karlin Jepsen, Mads Falk Klein, Ismail Gögenur, Tine Plato Kuhlma |
| A registry-based study on universal screening for defective mismatch repair in colorectal cancer in Denmark highlights disparities in screening uptake and counselling referrals. Translational oncology 2024 6 46 102013. Jon Ambæk Durhuus, Michael Galanakis, Thomas Maltesen, Christina Therkildsen, Susanne Rosthøj, Louise Laurberg Klarskov, Charlotte Kvist Lautrup, Ove Andersen, Mef Christina Nilbe |
| Clinicopathological significance and prognostic analysis of p21 and EGFR in colorectal cancer: a retrospective analysis on 12 319 cases in China. Journal of clinical pathology 2024 6 . Yang Fei, Mengke Ma, Lu Gan, Midie Xu, Yu Yang, Dan Huang, Weiqi She |
| Are sporadic colorectal cancers in young patients distinct from those in elderly patients? Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2024 6 . In Jun Yang, Duck-Woo Kim, Jeehye Lee, Hong-Min Ahn, Heung-Kwon Oh, Sung-Bum Kang, Jung Wook Suh, Min Hyun Kim, Hyeon Jeong Oh, Hyung Kyung Kim, Min Jung Kim, Ji Won Park, Seung-Bum Ryoo, Kyu Joo Park, Seung-Yong Jeong, Jae Hwan |
| KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients. Cancer control : journal of the Moffitt Cancer Center 2024 6 31 10732748241262179. Sara El Zaitouni, Abdelilah Laraqui, Meriem Ghaouti, Asmae Benzekri, Fouad Kettani, Tahar Bajjou, Yassine Sekhsokh, Soukaina Benmokhtar, Meryem Jafari, Walid Baba, Mohamed Oukabli, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Safae El Kochri, Idriss Amine Lahlou, Rabii Ameziane El Hassani, Khalid Enni |
| Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 6 50 (9): 108474. Ziming Gao, Xiang Qi, Ruiying Wang, Zhitong Wen, Hao Qi, Mingguang Ju, Xiaoxu Liu, Junye Wang, Heng Zhou, Zhi Zhu, Xiaofang Liu, Kai |
| Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients. Journal of gastrointestinal cancer 2024 5 . Zahra Mosaferi, Majid Pirestani, Ehsan Arefian, Goli Gojani, Nastaran Kavousinasab, Parto Karimi, Azam Deilami, Zahra Abrehdari-Tafres |
| KMT2A Mutations and High Prevalence of dMMR-associated Mutational Signatures as Prognostic Indicators in Metastatic Colorectal Cancer. Journal of Cancer 2024 5 15 (10): 3140-3150. Zhihang Han, Chuanjun Song, Dongqing Li, Weiyou Zhu, Jiukang Sun, Jialing Yao, Wenyuan Gan, Fufeng Wang, Xiaodong Yang, Lingjun Z |
| Exploring RAS mutation incidence and temporal heterogeneity in metastatic colorectal cancer patients - a single-institution experience utilising circulating tumour DNA. Contemporary oncology (Poznan, Poland) 2024 5 28 (1): 45-50. George Zarkavelis, Anna Lea Amylidi, Nanteznta Torounidou, Melina Yerolatsite, Athanasia Keravasili, Varvara Keramisanou, Davide Mau |
| Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies. Cancers 2024 5 16 (10): . Amit Mahipal, Michael H Storandt, Emily A Teslow, Ellen Jaeger, Melissa C Stoppler, Zhaohui Jin, Sakti Chakrabar |
| Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review. Diagnostics (Basel, Switzerland) 2024 5 14 (10): . Elena Orlandi, Mario Giuffrida, Serena Trubini, Enrico Luzietti, Massimo Ambroggi, Elisa Anselmi, Patrizio Capelli, Andrea Rombo |
| [Incidence of common gene mutations in early-onset colorectal cancer and the association with cancer survival: a meta-analysis]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2024 5 27 (5): 495-506. R Q Zhang, S H Li, T J Hu, L Y Xu, Y S Zhu, X |
| Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2024 5 . M Ambrosini, B Rousseau, P Manca, O Artz, A Marabelle, T André, G Maddalena, G Mazzoli, R Intini, R Cohen, A Cercek, N H Segal, L Saltz, A M Varghese, R Yaeger, M Nusrat, Z Goldberg, G Y Ku, I El Dika, O Margalit, A Grinshpun, P Kasi, R Schilsky, A Lutfi, E Shacham-Shmueli, M Khan Afghan, L Weiss, C B Westphalen, V Conca, B Decker, G Randon, E Elez, M Fakih, A B Schrock, C Cremolini, P Jayachandran, M J Overman, S Lonardi, F Pietranton |
| Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab. British journal of cancer 2024 5 . Koen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, Miriam Koopman, Petur Snaebjornsson, Anna J van Gestel, Geraldine R Vink, Jeanine M L Roodha |
| Monitoring ctDNA RAS Mutational Status in Metastatic Colorectal Cancer: A Trial Protocol of RAS-trace and RAS-trace-2 Studies. Journal of the anus, rectum and colon 2024 5 8 (2): 132-136. Kozo Kataoka, Takeshi Yamada, Manabu Shiozawa, Naoto Takase, Kazuma Ito, Kentaro Yamazaki, Jun Watanabe, Toshihiro Kudo, Takeshi Suto, Toshihiko Matsumoto, Kohei Murata, Yusuke Suwa, Shogen Boku, Hisateru Yasui, Nobuhisa Matsuhashi, Atsuyuki Maeda, Kiichi Sugimoto, Yusuke Matsumoto, Mitsuru Yokota, Johannes Fredebohm, Keita Mori, Masataka Ike |
- Page last reviewed:Feb 1, 2024
- Content source: